Actively Recruiting
Synbiotics in Patients at RIsk fOr Preterm Birth
Led by Ziekenhuis Oost-Limburg · Updated on 2026-02-27
402
Participants Needed
9
Research Sites
324 weeks
Total Duration
On this page
Sponsors
Z
Ziekenhuis Oost-Limburg
Lead Sponsor
F
Federaal Kenniscentrum voor Gezondheidszorg, Belgium
Collaborating Sponsor
AI-Summary
What this Trial Is About
Prematurity remains the main cause of death and serious health problems in new-borns. Besides the need for hospitalization and medical interventions in the first weeks or months of the new-borns' life, prematurity can cause long-lasting health problems (e.g. multiple hospital admissions, developmental delay, learning difficulties, motor delay, hearing or eye problems, ...). Moreover, prematurity places an enormous economic burden on the society. Aside from the medical problems and the financial cost, the emotional stress and psychological impact on the parents, siblings and other family members should not be underestimated. Previous preterm delivery (before 37 weeks of pregnancy) increases the risk for recurrent preterm delivery in a subsequent pregnancy. Therefore, these women should be considered as 'high risk' for preterm birth. Infections ascending from the vagina may be an important cause of preterm delivery in certain cases. Some women have an abnormal vaginal microbiome and are therefore at risk for infections and preterm birth. On the other hand, the vaginal flora is more stable and resistant to infections in healthy pregnant women who deliver at term (after 37 weeks of gestation). Synbiotics are a mixture containing probiotics and prebiotics. Probiotics are living bacteria with potential beneficial effects that can be used safely in pregnancy, while prebiotics are consumed by the bacteria. It is known that probiotics, when used for a long period of time, can maintain a healthy and stable vaginal flora that may protect against infections. In this study, pregnant patients with a history of preterm birth will be included in the first trimester of pregnancy to start with synbiotics or placebo. The investigators will examine the effect of synbiotics on the vaginal flora and on the pregnancy duration. The hypothesis is that synbiotics, when started early in the pregnancy, can change the disturbed vaginal flora into a stable micro-environment.
CONDITIONS
Official Title
Synbiotics in Patients at RIsk fOr Preterm Birth
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed written informed consent before any study assessments
- 18 years of age or older
- Singleton pregnancy
- Pregnancy consultation between 8 and 10 weeks gestation
- At least one of the following risk factors for spontaneous preterm birth: prior spontaneous preterm birth between 24 and 36 weeks, preterm premature rupture of membranes (PPROM) before 36 weeks in a previous pregnancy, or prior spontaneous second-trimester pregnancy loss between 14 and 24 weeks
You will not qualify if you...
- Currently using pro-, pre-, or synbiotics and unwilling to stop
- Multiple pregnancy
- Need for primary (type 1) cerclage
- Inflammatory bowel disease
- Known congenital uterine anomaly
- History of LLETZ conization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 9 locations
1
Universitaire Ziekenhuis Antwerpen
Edegem, Antwerpen, Belgium, 2650
Actively Recruiting
2
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium, 3600
Actively Recruiting
3
Universitaire Ziekenhuizen Leuven
Leuven, Limburg, Belgium, 3000
Actively Recruiting
4
CHR Citadelle
Liège, Liège, Belgium, 4000
Actively Recruiting
5
UZ Gent
Ghent, Oost-Vlaanderen, Belgium, 9000
Actively Recruiting
6
AZ Sint-Jan
Bruges, West-Vlaanderen, Belgium, 8300
Actively Recruiting
7
AZ Sint-Lucas
Bruges, West-Vlaanderen, Belgium, 8310
Actively Recruiting
8
AZ Maria Middelares
Ghent, West-Vlaanderen, Belgium, 9000
Actively Recruiting
9
AZ Groeninge
Kortrijk, Belgium, 8500
Actively Recruiting
Research Team
C
Caroline Van Holsbeke, PhD
CONTACT
K
Katrien Nulens, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here